Synaptic plasticity in animal models of early Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Synaptic plasticity in animal models of early Alzheimer's disease

Synaptic plasticity in animal models of early Alzheimer's disease

http://www.wikidata.org/entity/Q24675772

about

Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease Molecular basis of -amyloid oligomer recognition with a conformational antibody fragment Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease Long-term potentiation decay and memory loss are mediated by AMPAR endocytosis.Neuroregeneration in neurodegenerative disorders.Opposite effects of low and high doses of Abeta42 on electrical network and neuronal excitability in the rat prefrontal cortex.Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos.AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia Absent event-related potential (ERP) word repetition effects in mild Alzheimer's disease.Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice.Introduction. Long-term potentiation and structure of the issue The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice.A combination extract of ginseng, epimedium, polygala, and tuber curcumae increases synaptophysin expression in APPV717I transgenic mice Intracellular machinery for the transport of AMPA receptors Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?From amnesia to dementia: ERP studies of memory and language.Multiple effects of β-amyloid on single excitatory synaptic connections in the PFC.Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition.Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.Abnormal P600 word repetition effect in elderly persons with preclinical Alzheimer's disease.Amino acid position-specific contributions to amyloid beta-protein oligomerization.Pathway-specific alteration of synaptic plasticity in Tg2576 mice.Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity.Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials.Long-term potentiation (LTP) of human sensory-evoked potentials.Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.Recent Progress in Alzheimer's Disease Research, Part 1: Pathology.Endophilin2 Interacts with GluA1 to Mediate AMPA Receptor Endocytosis Induced by Oligomeric Amyloid-β.Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes Protective Effects of Proline-Rich Peptide in a Rat Model of Alzheimer Disease: An Electrophysiological Study.Cognitive event-related potentials: biomarkers of synaptic dysfunction across the stages of Alzheimer's disease.

P2860

Q24642355-A717B19A-0464-47BB-BE27-7EA951905B95 Q27670832-9BD3132C-D2DD-48A4-ACC9-FD83D1EB90A6 Q28578059-6BA32EE2-9FA9-407E-BF0E-3BA8E5D7F9F3 Q28595059-CC6F8A08-62AF-4601-9B03-F52EDA5FF1E4 Q30634653-8A1E8C13-A820-42F5-9408-F26295F86519 Q31020342-4A2A3735-CD8F-4D90-9DCA-5D9AED839B20 Q33520211-3A6EF207-9F4F-4F31-94A7-722946C1986F Q34067152-F5C06E01-94EE-4D85-9FA5-48317FFDACCD Q34203241-5FB333D2-4648-431C-8AB8-833D3626C56D Q34208684-7DE04BD3-7101-4EA0-89CF-DEA7C1226265 Q34360446-1885369A-94EB-43FB-A909-02A8A904235E Q34480004-B7E7F6D5-9150-4672-A501-68B8838E468E Q34767817-EA8CCC0B-0BCC-4895-8B0B-6C1F4FC7E076 Q34984088-2D50F4D5-4158-4982-B2CD-9998A43166E9 Q35084882-866683F9-05B2-46B4-BFD6-930372B419E7 Q35124797-ADD6081B-AB54-4035-BE9E-C489AA7635C2 Q35860467-CD751D4A-933B-4678-9592-E3CBBCCB8C12 Q35937611-4567D96F-391F-4BB9-9A6E-4A972072B5E9 Q36158722-02774D70-F6F8-46D2-B6BC-D0DE8FE50A82 Q36430458-21C3FCE8-56BC-497D-B0D5-6F12E63A8C58 Q36496985-3100C445-9841-4BB0-BD4C-D62EE9FE9C18 Q36607324-BE9B8F35-FF70-4225-89AB-FD6C8725351C Q36744065-D67F7022-6801-4044-B63F-9F61405CA1A9 Q37138837-E195CD32-4678-4F6B-BBA5-5C99BAF8C098 Q37149894-A4CB03C9-0567-412D-B0E9-5A61B1610373 Q37341124-0ACFA9C1-6193-45CE-9B42-4CE39518670E Q37343162-3123A03D-3F0A-4F28-879C-B77434DE2D01 Q37344434-79BD514D-C469-4EA7-BC65-E69249C91915 Q37358158-9B0480B2-5330-4A0A-9CD2-E76E49A3301B Q37461280-AB250902-6A6B-42D9-B65F-C1B4EA53E5AE Q37488142-D85F0998-BE73-45C1-B00A-9E842695C1A4 Q38014513-7E76D068-F15B-4791-AEC1-5E397B75032E Q38396369-F87F9F6E-B353-457C-91F5-47F682E4078C Q38566255-47B047E9-60A4-47FB-A61C-5C0217BB9177 Q38609997-88AC5D37-054B-4EAF-BA10-C4440EEEBE20 Q39145449-E3A36D9A-2444-4827-9CA7-9546467674AF Q41056746-3EB7A89A-AD6C-43B4-B06F-18ED4248BF1D Q41604924-060AA58E-1B89-4FDA-9DED-74099C379584 Q42123128-C639873E-D582-4AA9-887A-2BB348174B12 Q42588280-0D58889C-E05C-4E43-BC3A-58EE4AB0AE78

P2860

Synaptic plasticity in animal models of early Alzheimer's disease

http://www.wikidata.org/entity/Q24675772

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Synaptic plasticity in animal models of early Alzheimer's disease

@ast

Synaptic plasticity in animal models of early Alzheimer's disease

@en

Synaptic plasticity in animal models of early Alzheimer's disease

@nl

type

label

Synaptic plasticity in animal models of early Alzheimer's disease

@ast

Synaptic plasticity in animal models of early Alzheimer's disease

@en

Synaptic plasticity in animal models of early Alzheimer's disease

@nl

prefLabel

Synaptic plasticity in animal models of early Alzheimer's disease

@ast

Synaptic plasticity in animal models of early Alzheimer's disease

@en

Synaptic plasticity in animal models of early Alzheimer's disease

@nl

P1433

Q24675772-46A7123B-59F9-405A-9B7F-1D279323810C

P1476

Q24675772-A11229D5-1432-4645-89A1-61108BB28E61

P2093

Q24675772-12107622-E2C7-41E0-9F36-F037A05E3F56

Q24675772-1C3722B7-FF4F-4F0C-B342-426C18A41048

Q24675772-FDB2164F-9788-41F6-B0D5-4B998A8FF0D8

P2860

Q24675772-047094DC-1120-4381-8BEE-D81828ECCC72

Q24675772-04F19C8A-9928-4145-8D59-495E0BF38532

Q24675772-13B9819D-C30A-408B-9E88-530A500D523A

Q24675772-194E1B81-D82A-453F-B381-F6928372C405

Q24675772-1B478411-0B07-4E9F-805E-62D742A50C2F

Q24675772-1EEA035F-ACE4-48B6-BDE7-B72A1E7FE963

Q24675772-258AAA19-1B3C-4CA9-A2C4-586BC371120C

Q24675772-28CF6EEC-2B63-45D6-AD4F-48A1A8CDD72B

Q24675772-29E0E543-FF1A-4373-8814-CD7530BB31D9

Q24675772-2BA85A91-A431-4171-8028-37D92D0FF2CE

P304

Q24675772-5CD9A639-4557-4ACC-930D-FEA83558B058

P31

Q24675772-C271A254-6094-4F97-9967-81D5BF0360D2

P356

Q24675772-EC59C722-99CE-4BFE-A1A5-489EB825C20E

P407

Q24675772-BE4ED85B-F313-4799-A781-01A9350D8F81

P433

Q24675772-F43C763B-1AFC-4491-95F5-ED663902C186

P478

Q24675772-A19F7059-4004-4BDC-8BC6-872C5E3EBA5B

P50

Q24675772-A14CF26E-F5BD-47EE-8C66-CD2B7195B058

P577

Q24675772-74D3B89B-8197-46CA-9FDB-2D9B30BC64B1

P5875

Q24675772-CB42CE99-558E-4596-9FE6-30A87209EA17

P698

Q24675772-BF1D0B87-643E-4002-A674-F5D5D496D3F7

P921

Q24675772-8C1E37C6-C4DC-411E-96FC-E83161976945

P932

Q24675772-C3A46483-37AA-45E3-A1BB-532545C6E71A

P356

P1433

Philosophical Transactions of the Royal Society B

P1476

Synaptic plasticity in animal models of early Alzheimer's disease

@en

P2093

Igor Klyubin

http://www.w3.org/2001/XMLSchema#string

Roger Anwyl

http://www.w3.org/2001/XMLSchema#string

William K Cullen

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic neuroscience of mammalian learning and memory

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

Bidirectional synaptic plasticity: from theory to reality

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein

Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1

APP processing and synaptic plasticity in presenilin-1 conditional knockout mice

Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein

P304

821-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1098/RSTB.2002.1240

http://www.w3.org/2001/XMLSchema#string

P407

P433

1432

http://www.w3.org/2001/XMLSchema#string

P478

358

http://www.w3.org/2001/XMLSchema#string

P50

Michael J Rowan

P577

2003-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10766352

http://www.w3.org/2001/XMLSchema#string

P698

12740129

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1693153

http://www.w3.org/2001/XMLSchema#string